Koji Nakamura Selected Research

AS2553627

11/2018	Replacement of mycophenolate mofetil with a JAK inhibitor, AS2553627, in combination with low-dose tacrolimus, for renal allograft rejection in non-human primates.
1/2018	Prevention of chronic renal allograft rejection by AS2553627, a novel JAK inhibitor, in a rat transplantation model.
2/2017	AS2553627, a novel JAK inhibitor, prevents chronic rejection in rat cardiac allografts.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Koji Nakamura Research Topics

Disease

21	Neoplasms (Cancer) 03/2022 - 09/2009
14	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 01/2014
5	Autoimmune Diseases (Autoimmune Disease) 03/2022 - 01/2017
5	Pain (Aches) 01/2021 - 09/2007
5	Fibrosis (Cirrhosis) 11/2018 - 01/2016
4	Infections 06/2022 - 02/2005
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 03/2022 - 12/2021
3	Atrophy 11/2018 - 01/2016
3	Carcinoma (Carcinomatosis) 09/2018 - 07/2010
3	Inflammation (Inflammations) 01/2018 - 11/2013
2	Melanoma (Melanoma, Malignant) 03/2021 - 01/2020
2	Ovarian Epithelial Carcinoma 01/2019 - 11/2018
2	Neoplasm Metastasis (Metastasis) 05/2016 - 03/2012
2	Chorioamnionitis 03/2016 - 11/2013
1	Nephritis 03/2022
1	Proteinuria 03/2022
1	Glomerulonephritis 03/2022
1	Fetal Growth Retardation (Intrauterine Growth Retardation) 01/2022
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2022
1	Cough 01/2021
1	Lung Neoplasms (Lung Cancer) 01/2021
1	Multiple Myeloma 05/2020
1	Pancreatic Neoplasms (Pancreatic Cancer) 12/2019
1	Cholangiocarcinoma 12/2019
1	Vasculitis (Vasculitides) 11/2018
1	Chronic Hepatitis C 05/2018
1	Abdominal Pain (Pain, Abdominal) 01/2018
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2018
1	Fever (Fevers) 01/2018
1	Vertigo (Positional Vertigo) 01/2018
1	Adenocarcinoma 10/2017
1	Anemia 02/2017
1	Arthritis (Polyarthritis) 01/2017

Drug/Important Bio-Agent (IBA)

7	MicroRNAs (MicroRNA)IBA 03/2021 - 01/2014
5	Interleukin-6 (Interleukin 6)IBA 01/2018 - 01/2011
4	CytokinesIBA 03/2022 - 11/2013
4	Biomarkers (Surrogate Marker)IBA 09/2018 - 01/2014
3	AntigensIBA 06/2022 - 01/2021
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 08/2019
3	Monoclonal AntibodiesIBA 12/2019 - 09/2009
3	Pharmaceutical PreparationsIBA 01/2019 - 04/2015
3	AS2553627IBA 11/2018 - 02/2017
3	Janus Kinase InhibitorsIBA 01/2018 - 01/2017
3	Phosphotransferases (Kinase)IBA 02/2017 - 03/2016
2	AutoantibodiesIBA 03/2022 - 12/2021
2	Paclitaxel (Taxol)FDA LinkGeneric 10/2020 - 01/2019
2	LipidsIBA 08/2019 - 02/2015
2	Formaldehyde (Formol)FDA Link 02/2019 - 09/2007
2	VitronectinIBA 11/2018 - 10/2017
2	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 10/2017 - 05/2015
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2016 - 04/2015
2	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 01/2015 - 11/2013
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2013 - 01/2011
1	IpilimumabIBA 03/2022
1	AntibodiesIBA 03/2022
1	Programmed Cell Death 1 ReceptorIBA 03/2022
1	NivolumabIBA 03/2022
1	B7-H1 AntigenIBA 03/2022
1	cathepsin SIBA 03/2022
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 03/2022
1	Immunoglobulin G (IgG)IBA 03/2022
1	AutoantigensIBA 03/2022
1	CateninsIBA 01/2022
1	Tadalafil (Cialis)FDA Link 01/2022
1	Fc gamma receptor IIBIBA 01/2022
1	Transcription Factors (Transcription Factor)IBA 03/2021
1	RNA (Ribonucleic Acid)IBA 03/2021
1	LigandsIBA 01/2021
1	Lenalidomide (CC 5013)FDA Link 05/2020
1	Bortezomib (Velcade)FDA Link 05/2020
1	Complement System Proteins (Complement)IBA 01/2020
1	Photosensitizing Agents (Photosensitizers)IBA 12/2019
1	Nucleic AcidsIBA 08/2019
1	Type I Pituitary Adenylate Cyclase-Activating Polypeptide ReceptorsIBA 02/2019
1	Analgesics (Analgesic Drugs)IBA 02/2019
1	Fibronectins (Fibronectin)IBA 11/2018
1	Culture MediaIBA 11/2018
1	daclatasvirIBA 05/2018
1	asunaprevirIBA 05/2018
1	FicollIBA 01/2018
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2018
1	TNP-ficollIBA 01/2018
1	kamikihi-to (KKT)IBA 01/2018
1	Estrogens (Estrogen)FDA Link 01/2018
1	Plasminogen Activators (Plasminogen Activator)IBA 10/2017
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 10/2017
1	Focal Adhesion Protein-Tyrosine KinasesIBA 10/2017
1	Plasminogen Activator Inhibitor 1IBA 10/2017
1	IntegrinsIBA 10/2017
1	Erythropoietin FDA Link 02/2017
1	Tacrolimus (Prograf)FDA LinkGeneric 02/2017
1	Membrane Glycoproteins (Membrane Glycoprotein)IBA 01/2017

Therapy/Procedure

12	Therapeutics 12/2021 - 07/2010
3	Aftercare (After-Treatment) 01/2018 - 01/2003
2	Transplantation 02/2017 - 01/2016
1	Immunotherapy 03/2022
1	Oral Administration 03/2022
1	Radioimmunotherapy 01/2021
1	Intravenous Injections 12/2019
1	Kampo Medicine (Kampo) 01/2018